NCT00510809
Effect of Policosanol as Monotherapy and Adjunctive to Statin Therapy
Safety and Efficacy of Policosanol Monotherapy and When Added to Chronic Statin Therapy: A Pilot Study
James Backes, PharmD·ClinicalTrials.gov·drugCompleted
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- High Cholesterol
- Drug/Device/Intervention
- Policosanol
- Study type
- Interventional
- Intervention type
- drug
Sponsor & location
- Primary sponsor
- James Backes, PharmD
- Funder
- University of Kansas Medical Center
- Location
- Kansas City, United States of America
Timeline & enrollment
- Phase
- N/A
- Start date
- Jul 01, 2007
- End date
- May 01, 2010
- Enrollment
- 54 participants
Primary outcome
Lipid Profile
Summary
To determine the effects of policosanol on the cholesterol profile.
ICD-10 classifications
Cholesterolosis of gallbladderPure hypercholesterolaemiaOther disorders of lipoprotein metabolismDisorder of lipoprotein metabolism, unspecifiedDisorders of lipoprotein metabolism and other lipidaemias
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT00510809
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT00510809 through Pure Global AI's free database. This phase not specified trial is sponsored by James Backes, PharmD and is currently Completed. The study focuses on High Cholesterol. Target enrollment is 54 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.